Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167–78. https://doi.org/10.1002/nau.10052.
Zhang L, Cai N, Mo L, Tian X, Liu H, Yu B. Global prevalence of overactive bladder: a systematic review and meta-analysis. Int Urogynecol J. 2025;36(8):1547–66. https://doi.org/10.1007/s00192-024-06029-2.
Article PubMed PubMed Central Google Scholar
Levy G, Lowenstein L. Overactive bladder syndrome treatments and their effect on female sexual function: a review. Sex Med. 2020;8(1):1–7. https://doi.org/10.1016/j.esxm.2019.08.013.
Ruff L, Bagshaw E, Aracil J, Velard M, Pardhanani G, Hepp Z. Economic impact of onabotulinumtoxinA for overactive bladder with urinary incontinence in Europe. J Med Econ. 2016;19(12):1107–15. https://doi.org/10.1080/13696998.2016.1199430.
Pelling M, Hammett J, Patil D. Long-term cost analysis of third-line treatment options for overactive bladder. Urol Pract. 2024;11(1):62–9. https://doi.org/10.1097/UPJ.0000000000000474.
Powell LC, Szabo SM, Walker D, Gooch K. The economic burden of overactive bladder in the United States: a systematic literature review. Neurourol Urodyn. 2018;37(4):1241–9. https://doi.org/10.1002/nau.23477.
Lightner DJ, Gomelsky A, Souter L, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment 2019. J Urol. 2019;202(3):558–63. https://doi.org/10.1097/JU.0000000000000309.
Lo CW, Wu MY, Yang SS, Jaw F, Chang S. Comparing the efficacy of onabotulinumtoxinA, sacral neuromodulation, and peripheral tibial nerve stimulation as third-line treatment for the management of overactive bladder symptoms in adults: systematic review and network meta-analysis. Toxins (Basel). 2020;12(2):128. https://doi.org/10.3390/toxins12020128.
Article CAS PubMed PubMed Central Google Scholar
Chung E, Lee D, Gani J, Gillman M, Maher C, Brennan J, et al. Position statement: a clinical approach to the management of adult non-neurogenic overactive bladder. Med J Aust. 2018;208(1):41–5. https://doi.org/10.5694/mja16.01097.
Roman MP, Ciortea R, Doumouchtsis SK, Măluțan AM, Bucuri CE, Ormindean CM, et al. Comparison of different treatment outcomes for refractory overactive bladder: a systematic review and meta-analysis. Toxins (Basel). 2025;17(10):479. https://doi.org/10.3390/toxins17100479.
Article CAS PubMed PubMed Central Google Scholar
Tutolo M, Ammirati E, Heesakkers J, Kessler TM, Peters KM, Rashid T, et al. Efficacy and safety of sacral and percutaneous tibial neuromodulation in non-neurogenic lower urinary tract dysfunction and chronic pelvic pain: a systematic review of the literature. Eur Urol. 2018;73(3):406–18. https://doi.org/10.1016/j.eururo.2017.11.002.
Wibisono E, Rahardjo HE. Effectiveness of short term percutaneous tibial nerve stimulation for non-neurogenic overactive bladder syndrome in adults: a meta-analysis. Acta Med Indones. 2015;47(3):188–200.
Burton C, Sajja A, Latthe PM. Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: a systematic review and meta-analysis. Neurourol Urodyn. 2012;31(8):1206–16. https://doi.org/10.1002/nau.22251.
Article CAS PubMed Google Scholar
Soetoko AS, Fatmawati D. Anatomical variations of the tibial nerve and their clinical correlation. Anat Cell Biol. 2023;56(4):415–20.
Article PubMed PubMed Central Google Scholar
Granger CJ, Cohen-Levy WB. In: StatPearls, editor. Anatomy, bony pelvis and lower limb: posterior tibial nerve. Treasure Island (FL): StatPearls Publishing; 2025. https://www.ncbi.nlm.nih.gov/books/NBK546623/
Elbarrany WG, Altaf FM. The tibial nerve and its vasculature: an anatomical evaluation. Int J Morphol. 2017;35(3):812–9.
Priya A, Ghosh SK, Walocha JA, Tubbs RS, Iwanaga J. Variations in the branching pattern of tibial nerve in foot: a review of literature and relevant clinical anatomy. Folia Morphol (Warsz). 2023;82(2):231–41.
Article CAS PubMed Google Scholar
Torres ALG, Ferreira MC. Study of the anatomy of the tibial nerve and its branches in the distal medial leg. Acta Ortop Bras. 2012;20(3):157–64.
Article PubMed PubMed Central Google Scholar
Juenemann KP, Lue TF, Schmidt RA, Tanagho EA. Clinical significance of sacral and pudendal nerve anatomy. J Urol. 1988;139(1):74–80.
Article CAS PubMed Google Scholar
Schmidt RA, Senn E, Tanagho EA. Functional evaluation of sacral nerve root integrity: report of a technique. Urology. 1990;35(5):388–92.
Article CAS PubMed Google Scholar
Tanagho EA, Schmidt RA. Electrical stimulation in the clinical management of the neurogenic bladder. J Urol. 1988;140(6):1331–9.
Article CAS PubMed Google Scholar
Chancellor MB, Chartier-Kastler E. Principles of sacral nerve stimulation for the treatment of bladder and urethral sphincter dysfunctions. Neuromodulation. 2000;3(1):15–26.
De Groat WC, Theobald RJ. Reflex activation of sympathetic pathways to vesical smooth muscle and parasympathetic ganglia by electrical stimulation of vesical afferents. J Physiol. 1976;259(1):223–37.
Article PubMed PubMed Central Google Scholar
De Groat WC. Nervous control of the urinary bladder of the cat. Brain Res. 1975;87(2–3):201–11.
Leng WW, Chancellor MB. How sacral nerve stimulation neuromodulation works. Urol Clin North Am. 2005;32(1):11–8.
Craggs M, McFarlane J. Neuromodulation of the lower urinary tract. Exp Physiol. 1999;84:149–60.
Article CAS PubMed Google Scholar
Aoki Y, Brown HW, Brubaker L, Cornu JN, Daly JO, Cartwright R. Urinary incontinence in women. Nat Rev Dis Primers. 2017;3:17042.
Article PubMed PubMed Central Google Scholar
Wyndaele M, Hashim H. Pathophysiology of urinary incontinence. Surg (Oxford). 2017;35(6):287–92.
Fowler CJ, Griffiths D, De Groat WC. The neural control of micturition. Nat Rev Neurosci. 2008;9:453–66.
Article CAS PubMed PubMed Central Google Scholar
Griffiths D. Neural control of micturition in humans: a working model. Nat Rev Urol. 2015;12:695–705.
Article CAS PubMed Google Scholar
Dequirez PL, De Wachter S, Biardeau X. Sacral neuromodulation for lower urinary tract dysfunction: overview and mechanisms of action. Auton Neurosci. 2025;261:103337.
Article CAS PubMed Google Scholar
Erol B, Danacioglu YO, Peters KM. Current advances in neuromodulation techniques in urology practices: a review of literature. Turk J Urol. 2022;47(5):375–85.
Malde S, Fry C, Schurch B, Marcelissen T, Averbeck M, Digesu A, et al. What is the exact working mechanism of botulinum toxin A and sacral nerve stimulation in the treatment of overactive bladder/detrusor overactivity? ICI-RS 2017. Neurourol Urodyn. 2018;37(S4):S108–16. https://doi.org/10.1002/nau.23552.
Comments (0)